ENA Respiratory, a clinical-stage pharmaceutical firm focused on creating antiviral host defense immune boosters to reduce the effects of viral respiratory infections in vulnerable groups, reports that it has successfully finalized dosing for the...
The Indian pharmaceutical and healthcare sector holds significant hopes for the forthcoming Union Budget 2025, as stated in a report by CareEdge Ratings. The industry is requesting greater government assistance to enhance infrastructure and...
Emcure Pharmaceuticals Ltd, based in Pune, opened its largest Formulation Research and Development Centre in Ahmedabad, aimed at facilitating advancements in complex drug delivery methods. The newly established Emcure Research Centre will...
The cell therapy market is swiftly progressing, propelled by significant breakthroughs in medical research and a growing embrace of novel treatments in various therapeutic fields. The global industry is estimated to be valued at US$ 4.8 billion in...
Conduit Pharmaceuticals Inc. announced that it has established a strategic services partnership with the formulation development CDMO Agility Life Sciences (“Agility”) to create new solid oral-dosage form products for its autoimmune pipeline...
Tris Pharma, Inc. (Tris), a biopharmaceutical company in the commercial stage, revealed encouraging topline findings from its ALLEVIATE-1 crucial Phase 3 clinical trial assessing cebranopadol, an experimental treatment, for addressing moderate-to...
Roche reported that the US Food and Drug Administration (FDA) has provided 510(k) clearance and a Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver for its cobas liat panels for multiplex testing of sexually transmitted infections...
Poxel SA, a biopharmaceutical firm at the clinical stage focusing on developing groundbreaking therapies for chronic serious diseases characterized by metabolic pathophysiology, such as metabolic dysfunction-associated steatohepatitis (MASH)...
Hoth Therapeutics, Inc., a biopharmaceutical firm centered on patients, is pleased to announce progress in its intellectual property holdings by acquiring and expanding patent applications related to its cutting-edge therapeutic pipeline...
Opella, the Consumer Healthcare division of Sanofi, announced that the US Food and Drug Administration (FDA) has removed a clinical hold on its proposed actual use trial (AUT) aimed at facilitating the transition of Cialis (tadalafil) from...